Xudong Ding
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Empagliflozin, a sodium-glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome.
Journal: Journal of cellular physiology
Published: September 05, 2023
Mitochondrial DNA abnormalities and metabolic syndrome.
Journal: Frontiers in cell and developmental biology
Published: January 29, 2023
Mitophagy Disequilibrium, a Prominent Pathological Mechanism in Metabolic Heart Diseases.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: August 30, 2021
Therapeutic Effects of Coccomyxagloeobotrydiformis on the Metabolic Syndrome in Rats.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: February 04, 2018
Nerve growth factor pretreatment inhibits lidocaine‑induced myelin damage via increasing BDNF expression and inhibiting p38 mitogen activation in the rat spinal cord.
Journal: Molecular medicine reports
Published: September 07, 2016
PDK1 Activity Regulates Proliferation, Invasion and Growth of Hemangiomas.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 22, 2015
Low concentration of rapamycin inhibits hemangioma endothelial cell proliferation, migration, and vascular tumor formation in mice.
Journal: Current therapeutic research, clinical and experimental
Published: September 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026